It's quick and easy to access Live Science Plus, simply enter your email below. We'll send you a confirmation and sign you up for our daily newsletter, keeping you up to date with the latest science news.
A 3D rendering of the Air Barrier System area of protection. The blue shaded part represents a 90 percent or greater reduction in airborne contamination over an area approximately 20" long by 6" wide. The grey zone represents the 80 percent or greater reduction area.
This Behind the Scenes article was provided to LiveScience in partnership with the National Science Foundation.
This spring, Nimbic Systems, based near Houston, Texas, received FDA clearance for their Air Barrier System, a unique medical device for reducing surgical-incision site contamination by infection-causing microorganisms.
The Air Barrier System, or ABS, creates a "cocoon" of highly pure air that surrounds a surgical incision site. The cocoon isolates the incision from ambient air to prevent the bacteria present in the operating room from harming the patient.
Latest Videos From
During surgery, bacteria are continuously shed by operating room personnel into the air and can subsequently settle in and around an incision site. The organisms, such as Staphylococcus aureus, are a major cause of infections in prosthesis implant surgeries such as hip and knee replacements.
The ABS device
The Air Barrier System nozzle pictured is deployed on the sterile field just prior to incision during a hip arthroplasty procedure.
(Image credit: Nimbic Systems, Inc.)
The portable ABS device prevents contamination without disrupting the surgical procedure or impeding access to the incision area, making it relatively easy to use.
The ABS consists of two components: A non-sterile, reusable blower unit that provides the source of HEPA filtered air; and a sterile, disposable nozzle that is affixed onto the surgical drape adjacent to the incision.
Sign up for the Live Science daily newsletter now
Get the world’s most fascinating discoveries delivered straight to your inbox.
In 2009, Nimbic Systems received funding from the National Science Foundation to conduct ABS pilot trials, with the goal of determining the degree to which localized, directed HEPA air flow generated by the ABS reduced the amount of airborne particulates and colony-forming bacteria in the surgical field and wound during total hip arthroplasty.
Surgical intervention
The ABS system can reduce the number and size of bacterial colonies that grow on a nutrient rich broth in the lab.
(Image credit: Nimbic Systems, Inc.)
Orthopedic joint arthroplasty, spinal procedures, thoracic and vascular procedures, and other long-duration procedures are high-risk for infection. Not only is the risk of harm to the patient a concern, but costs from the infections can reach up to to $100,000.
The results of the preliminary hip arthroplasty trial revealed that the ABS reduces the presence of microorganisms at the incision site by greater than 84 percent.
Based on the data obtained in the pilot trials, the FDA approved the ABS for use in hip arthroplasty procedures, while future trials planned for later this year will investigate spine and femoral popliteal procedures.
Editor's Note: This research was supported by the National Science Foundation, the federal agency charged with funding basic research and education across all fields of science and engineering. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author and do not necessarily reflect the views of the National Science Foundation. See the Behind the Scenes Archive.
Live Science Plus
